As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.
6 Analysts have issued a Profound Medical Corp forecast:
6 Analysts have issued a Profound Medical Corp forecast:
Jun '25 |
+/-
%
|
||
Revenue | 12 12 |
50%
50%
|
|
Gross Profit | 8.22 8.22 |
71%
71%
|
|
EBITDA | -42 -42 |
40%
40%
|
EBIT (Operating Income) EBIT | -42 -42 |
38%
38%
|
Net Profit | -41 -41 |
48%
48%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, CA.
Head office | Canada |
CEO | Arun Menawat |
Employees | 142 |
Founded | 2008 |
Website | profoundmedical.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.